Berkeley Capital Partners, LLC Novartis Ag Transaction History
Berkeley Capital Partners, LLC
- $357 Million
- Q4 2024
A detailed history of Berkeley Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Berkeley Capital Partners, LLC holds 2,408 shares of NVS stock, worth $260,112. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,408
Previous 6,016
59.97%
Holding current value
$260,112
Previous $691,000
66.14%
% of portfolio
0.07%
Previous 0.2%
Shares
28 transactions
Others Institutions Holding NVS
# of Institutions
1,474Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.32 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.19 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$884 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$742 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$602 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $232B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...